• Cesca Therapeutics’ Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR-T Manufacturing Process in Cell & Gene Therapy

    Source: Nasdaq GlobeNewswire / 23 May 2018 08:30:45   America/New_York

    N/A
Share on,